⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14725593 | 0.86 | — | — | |
| SCHEMBL14725592 | 0.81 | — | — | |
| SCHEMBL14725591 | 0.81 | MAPT (0.32) | — | |
| SCHEMBL14725588 | 0.77 | — | — | |
| SCHEMBL14725587 | 0.70 | ZDHHC20 (0.35) | — | |
| SCHEMBL18752084 | 0.70 | — | — | |
| SCHEMBL13403089 | 0.68 | RIPK1 (0.33) | — | |
| SCHEMBL12603383 | 0.68 | PAOX (0.31) | — | |
| SCHEMBL13253170 | 0.67 | — | — | |
| SCHEMBL12603384 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9198972-B2 | Monomers and oligonucleotides comprising cycloaddition adduct(s) | ALNYLAM PHARMACEUTICALS, INC. (US) | 2015-12-01 | — | — | US | disclosed |
| US-20130053334-A1 | MONOMERS AND OLIGONUCLEOTIDES COMPRISING CYCLOADDITION ADDUCT(S) | ALNYLAM PHARMACEUTICALS, INC. (US) | 2013-02-28 | — | — | US | disclosed |